Senior insider sale
President & CEO at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$6.70M
43.13K shares
What this filing means
HASSANEIN WALEED H plans to sell 43.13K shares of TRANSMEDICS GROUP, INC. valued at approximately $6.70M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2024ACC: 0001968582-24-000706
DirectorOfficer· President & CEO
Since May 2019
43.13K
Shares to sell
$6.70M
Approx. market value
25.88K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/15/2024
25.88KTotal acquired25.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2024 | Stock Option Exercise Cash | 25.88K | — |
| Total | 25.88K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
8.63K
Market value
$1.25M
7/15/2024
—Completed
Units to sell
8.63K
Market value
$1.22M
6/14/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.88K
Market value
$4.22M
8/15/2024
Total
Units
43.13K
Value
$6.70M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/15/2024 | 8.63K | $1.25M | — | Completed |
6/14/2024 | 8.63K | $1.22M | — | Completed |
| Planned — Approximate Date | ||||
8/15/2024 | 25.88K | $4.22M | NASDAQ | Planned |
| Total | 43.13K | $6.70M | ||